Literature DB >> 9921378

The situation of hepatosplenic schistosomiasis in Brazil today.

Z A Andrade1.   

Abstract

Specific chemotherapy against schistosomiasis together with environmental changes occurring in endemic areas of Brazil are causing a revolution in the clinico-pathological presentation of the disease when comparing to date from 10 to 15 years ago. To update the subject, an inquiry was made among the most experienced Brazilian investigators in this field. They agree that a decrease of about 50 to 70% in prevalence, and an even higher decrease in incidence are taking place in Brazil today. The prevalence of schistosome-infection has decreased in some areas and increased in other, with spreading sometimes occurring to peri-urban regions, indicating that schistosomiasis control depends on the application of multiple measures. General clinical and pathological manifestations related to hepatosplenic disease, such as ascites, gastric hemorrhages, big-spleen syndrome, cor pulmonale, glomerulopathy, etc. are also less severe nowadays than they used to be in the past.

Entities:  

Mesh:

Year:  1998        PMID: 9921378     DOI: 10.1590/s0074-02761998000700062

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

1.  Environmental effects on parasitic disease transmission exemplified by schistosomiasis in western China.

Authors:  Song Liang; Edmund Y W Seto; Justin V Remais; Bo Zhong; Changhong Yang; Alan Hubbard; George M Davis; Xueguang Gu; Dongchuan Qiu; Robert C Spear
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

2.  Potential role of the chemokine macrophage inflammatory protein 1alpha in human and experimental schistosomiasis.

Authors:  Adriano L S Souza; Ester Roffê; Vanessa Pinho; Danielle G Souza; Adriana F Silva; Remo C Russo; Rodrigo Guabiraba; Cíntia A J Pereira; Flávia M Carvalho; Michele M Barsante; Rodrigo Correa-Oliveira; Lúcia A O Fraga; Deborah Negrão-Correa; Mauro M Teixeira
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection.

Authors:  Xiaoxia Wang; David Gurarie; Peter L Mungai; Eric M Muchiri; Uriel Kitron; Charles H King
Journal:  PLoS Negl Trop Dis       Date:  2012-11-15

4.  Control efficacy of annual community-wide treatment against Schistosoma japonicum in China: a meta-analysis.

Authors:  Jing Su; Da-Bing Lu; Xia Zhou; Su-Rong Wang; Hong-Xiang Zhuge
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

5.  Prevalence and Morbidity Data on Schistosoma mansoni Infection in Two Rural Areas of Jequitinhonha and Rio Doce Valleys in Minas Gerais, Brazil.

Authors:  Maria José Conceição; Aline Eduardo Carlôto; Eric Vinaud de Melo; Iran Mendonça da Silva; José Rodrigues Coura
Journal:  ISRN Parasitol       Date:  2013-03-19

6.  The cost-effectiveness of schistosomiasis screening and treatment among recently resettled refugees to Canada: an economic evaluation.

Authors:  John A Webb; Gabriel Fabreau; Eldon Spackman; Stephen Vaughan; Kerry McBrien
Journal:  CMAJ Open       Date:  2021-02-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.